Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all.

As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.

Company number: 0744643660 
VAT: BE0744643660 

Biotechnology

Life Sciences

Pharmaceutical

Exothera

Exothera's headquarters in Jumet, Belgium

Hanna Lesch

Lander Monné

Vladimir Ivošev

Vincent Dubois

Fabien Baldacci-Cresp

Thomas le Gall

Sylvia Haller

Dmitry Sorokin

Vincent Goossens

Antoine Melchior

Benjamin Depierreux

Céline Delecourt

Cédric Meeüs

Koen Coorevits

Tiago Albano

Nicolas D'Udekem

Nicolas Delrée

Thibaut Martin

Antonio Salgado-Somoza

Description

People (14)